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Introduction
The Scandinavian Starch for Severe Sepsis/Septic Shock
(6S) trial [1] showed increased mortality in patients with
severe sepsis resuscitated with hydroxyethyl starch
130/0.42 (HES) vs. Ringer’s acetate. The underlying patho-
physiological mechanisms are, however, not fully eluci-
dated. The endothelium may be important for the effects
of fluid therapy, and the different fluids may impact the
endothelium differently.
Objectives
We aimed to investigate associations between HES vs.
Ringer’s and plasma biomarkers reflecting endothelial
damage and function, including its natural anticoagulant
systems, and if they were associated with 90-day mortality.
We hypothesized that allocation to HES increased
endothelial dysfunction and hence mortality.
Methods
Six biomarkers: soluble trombomodulin (sTM); syndecan-
1; soluble CD40 ligand (sCD40L); plasminogen activator
inhibitor-1 (PAI-1); tissue-type plasminogen activator
(tPA) and protein C were assessed in a subgroup of
208 patients from the 6S trial [1]. We analyzed differences
in plasma concentration from baseline to day 2 after ran-
domisation in the two intervention groups using linear or
logistic regression models. Multiple imputations were used
for missing data and the analyses were adjusted for stratifi-
cation variables (university hospital, shock and hematolo-
gic malignancy) and baseline SAPS II and use of plasma.
Results
At baseline the HES vs. Ringer’s groups were comparable
regarding age (median 66 vs. 66, p = 0.69), disease severity
(SAPS II (52 vs. 55, p = 0.73)) and type of admission (sur-
gical 45% vs. 39%, p= 0.35). Also, the baseline concentra-
tions of the biomarkers did not differ between the
intervention groups. The masked trial fluid was adminis-
tered in comparable volumes in the HES vs. Ringer’s
groups in the first 2 days (2250 ml vs. 2500 ml; p = 0.73).
In both adjusted and unadjusted analyses the Ringer’s
group had a higher increase in plasma sTM (baseline to
day 2) as compared to the HES group (1.78 ng/ml; 95%
confidence interval (CI) 2.88 to 0.67; p = 0.002). However,
sTM was not associated with mortality; increase in PAI-1
was the only biomarker change associated with 90-day
mortality (odds ratio for 1 unit increase was 1.04; 95 %
CI 1.01-1.08; p = 0.01).
Conclusions
We could not confirm that HES increased endothelial dys-
function in this population. On the contrary, the Ringer’s
group had higher circulating sTM concentrations on day 2
indicating increased endothelial damage. Thus, the
increased mortality observed with HES in patients with
severe sepsis may not be explained by endothelial
dysfunction.
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